"FTC Investigates Middlemen's Role in Generic Drug Shortages"
TL;DR
The Biden administration is investigating the role of drug wholesalers and group purchasing organizations in causing shortages of generic drugs, which make up the majority of prescriptions in the U.S. The Federal Trade Commission and the Department of Health and Human Services are seeking public input on whether these middlemen have used their market power to drive down prices to the point where manufacturers can't profit, leading to production stoppages and discouraging competition. The public will have 60 days to submit comments, and the investigation comes amid ongoing efforts to address high drug costs.
Topics:businesshealth-and-pharmaceuticals#biden-administration#drug-shortages#federal-trade-commission#generic-drugs#health-and-pharmaceuticals#supply-chain
- Biden administration examining role of supply chain middlemen in generic drug shortages CNBC
- Drug Shortages Trigger FTC Probe - WSJ The Wall Street Journal
- FTC probing drug 'middlemen' over 'critical' generic shortages at hospitals: 'Endangering patients' New York Post
- US FTC to probe shortage of drugs, chemotherapies in hospitals XM
- FTC and HHS Launch Probe of Ongoing Generic Drug Shortages BioSpace
Want the full story? Read the original reporting
Read on CNBC